Skip to main content

The Globe and Mail

Walgreens to buy 40-per-cent stake in Chinese pharmacy chain

A Walgreens store in New York.

MIKE SEGAR/REUTERS

Walgreens Boots Alliance Inc said it would buy a 40 per cent stake in Chinese pharmacy chain operator Sinopharm Holding GuoDa Drugstores Co Ltd, as the U.S. drugstore chain seeks to expand in the country's fast-growing healthcare market.

Walgreens, the biggest U.S. drugstore chain, said on Wednesday it would buy the minority stake from China National Accord Medicines Corp Ltd for about $416-million.

The deal comes when the Chinese government has been encouraging private investments and equity from abroad in its healthcare industry.

Story continues below advertisement

Healthcare expenditure in China is expected to reach $1.1-trillion by 2020, according to an estimate by the U.S. Department of Commerce.

GuoDa, which operates and franchises 3,500 retail pharmacies across 70 cities in China, said the Walgreens investment would help its nationwide expansion plans.

Report an error
As of December 20, 2017, we have temporarily removed commenting from our articles as we switch to a new provider. We are behind schedule, but we are still working hard to bring you a new commenting system as soon as possible. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.